前往化源商城

2,1,3-Benzoxadiazole-4-sulfonamide, 7-[(2-aminoethyl)amino]-N-[2-(dimethylamino)ethyl]

2,1,3-Benzoxadiazole-4-sulfonamide, 7-[(2-aminoethyl)amino]-N-[2-(dimethylamino)ethyl]结构式
2,1,3-Benzoxadiazole-4-sulfonamide, 7-[(2-aminoethyl)amino]-N-[2-(dimethylamino)ethyl]结构式
品牌特惠专场
常用名 2,1,3-Benzoxadiazole-4-sulfonamide, 7-[(2-aminoethyl)amino]-N-[2-(dimethylamino)ethyl] 英文名 2,1,3-Benzoxadiazole-4-sulfonamide, 7-[(2-aminoethyl)amino]-N-[2-(dimethylamino)ethyl]
CAS号 913253-56-2 分子量 328.39100
密度 N/A 沸点 N/A
分子式 C12H20N6O3S 熔点 N/A
MSDS 中文版 美版 闪点 N/A

Rapid UPLC-MS/MS method for routine analysis of plasma pristanic, phytanic, and very long chain fatty acid markers of peroxisomal disorders.

J. Lipid Res. 49 , 1855-1862, (2008)

Quantification of pristanic acid, phytanic acid, and very long chain fatty acids (i.e., hexacosanoic, tetracosanoic, and docosanoic acids) in plasma is the primary method for investigateing a multitude of peroxisomal disorders (PDs). Typically based on GC-MS,...

Synthesis of benzofurazan derivatization reagents for carboxylic acids and its application to analysis of fatty acids in rat plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry.

Biomed. Chromatogr. 19 , 802-808, (2005)

The derivatization regents for carboxylic acids, DAABD-AE (4-[2-(N,N-dimethylamino)ethylaminosulfonyl]7-(2-aminoethylamino)-2,1,3-benzoxadiazole), MePZBD-AE ([4-(4-N-methyl)piperazinosulfonyl]-7-(2-aminoethylamino)-2,1,3-benzoxadiazole) and APZBD-NHMe ([4-(4-...